Background: Zinc has a critical role in metabolism and growth. This study aims to determine the effects of low-energy diets differing in macronutrient composition on zinc intake, estimated zinc bioavailability (phytate:zinc molar ratio) and plasma zinc concentration and associations between zinc status and cardiometabolic markers in obese adolescents with clinical insulin resistance (IR). Methods: Eighty-seven obese adolescents (10-17 years, body mass index z-score 2.3 ± 0.37) with clinical IR were randomized to a low-energy diet (6.0-8.0 MJ), which was either high carbohydrate or moderate carbohydrate with increased protein. Twenty-four-hour dietary recalls were collected at 6, 9 and 12 weeks. Plasma zinc concentration and cardiometabolic markers were assessed at baseline and 12 weeks. Results: Zinc intake did not differ between the 2 diet groups (p = 0.612). The high-carbohydrate group had a higher phytate intake (894 vs. 671 mg, p = 0.018) and phytate:zinc molar ratio (9.4 vs. 7.4, p = 0.009) than the increased-protein group. Plasma zinc concentration did not change from baseline in either of the diet groups, but correlated positively with zinc intake (r = 0.235, p = 0.042) and % energy from protein (r = 0.383, p = 0.001), and inversely with % energy from carbohydrate (r = -0.296, p = 0.010). Conclusions: Low energy diets for obese adolescents at risk of diabetes may need increased protein content to optimize zinc bioavailability.

1.
Gibson RS: A historical review of progress in the assessment of dietary zinc intake as an indicator of population zinc status. Adv Nutr 2012;3:772-782.
2.
Gibson RS, Heath AL, Ferguson EL: Risk of suboptimal iron and zinc nutriture among adolescent girls in Australia and New Zealand: causes, consequences, and solutions. Asia Pac J Clin Nutr 2002;11(suppl 3):S543-S552.
3.
Foster M, Samman S: Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus. Antioxid Redox Signal 2010;13:1549-1573.
4.
Vashum KP, McEvoy M, Shi Z, Milton AH, Islam MR, Sibbritt D, et al: Is dietary zinc protective for type 2 diabetes? Results from the Australian longitudinal study on women's health. BMC Endocr Disord 2013;13:40.
5.
Sun Q, van Dam RM, Willett WC, Hu FB: Prospective study of zinc intake and risk of type 2 diabetes in women. Diabetes Care 2009;32:629-634.
6.
Ortega RM, Rodríguez-Rodríguez E, Aparicio A, Jiménez AI, López-Sobaler AM, González-Rodríguez LG, et al: Poor zinc status is associated with increased risk of insulin resistance in Spanish children. Br J Nutr 2012;107:398-404.
7.
Suliburska J, Cofta S, Gajewska E, Kalmus G, Sobieska M, Samborski W, et al: The evaluation of selected serum mineral concentrations and their association with insulin resistance in obese adolescents. Eur Rev Med Pharmacol Sci 2013;17:2396-2400.
8.
García OP, Ronquillo D, del Carmen Caamaño M, Martínez G, Camacho M, López V, et al: Zinc, iron and vitamins A, C and E are associated with obesity, inflammation, lipid profile and insulin resistance in Mexican school-aged children. Nutrients 2013;5:5012-5030.
9.
Gibson RS: Principles of Nutritional Assessment, ed 2. Oxford University Press, 2005.
10.
Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, et al: Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008;31(suppl 1):S61-S78.
11.
Gow ML, Ho M, Burrows TL, Baur LA, Stewart L, Hutchesson MJ, et al: Impact of dietary macronutrient distribution on BMI and cardiometabolic outcomes in overweight and obese children and adolescents: a systematic review. Nutr Rev 2014;72:453-470.
12.
Garnett SP, Baur LA, Noakes M, Steinbeck K, Woodhead HJ, Burrell S, et al: Researching effective strategies to improve insulin sensitivity in children and teenagers - RESIST. A randomised control trial investigating the effects of two different diets on insulin sensitivity in young people with insulin resistance and/or pre-diabetes. BMC Public Health 2010;10:575.
13.
Garnett SP, Gow M, Ho M, Baur LA, Noakes M, Woodhead HJ, et al: Optimal macronutrient content of the diet for adolescents with prediabetes; RESIST a randomised control trial. J Clin Endocrinol Metab 2013;98:2116-2125.
14.
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320:1240-1243.
15.
American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31(suppl 1):S55-S60.
16.
Australian Government Department of Health and Ageing. 2007 Australian National Children's Nutrition and Physical Activity Survey - User Guide. http://www.health.gov.au/internet/main/publishing.nsf/Content/phd-nutrition-childrens-survey-userguide (accessed May 12, 2015).
17.
Hartley NK: Phytate and Zinc intakes of New Zealand Toddlers Aged 12-24 Months. University of Otago, 2014.
18.
International Zinc Nutrition Consultative Group: Determining the Prevalence of Zinc Deficiency: Assessment of Dietary Zinc Intake. IZiNCG Technical Brief, 2007.
19.
National Health and Medical Research Council: Nutrient Reference Values for Australia and New Zealand. Canberra, Commonwealth of Australia, 2006. https://www.nrv.gov.au (accessed June 18, 2014).
20.
Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470.
21.
Alberti KG, Zimmet P, Shaw J: International diabetes federation: a consensus on type 2 diabetes prevention. Diabet Med 2007;24:451-463.
22.
National high blood pressure education program working group on high blood pressure in children adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2 suppl):555-576.
23.
Chimienti F: Zinc, pancreatic islet cell function and diabetes: new insights into an old story. Nutr Res Rev 2013;26:1-11.
24.
Capdor J, Foster M, Petocz P, Samman S: Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans. J Trace Elem Med Biol 2013;27:137-142.
25.
Rangan AM, Samman S: Zinc intake and its dietary sources: results of the 2007 Australian national children's nutrition and physical activity survey. Nutrients 2012;4:611-624.
26.
National Health and Medical Research Council: Australian Dietary Guidelines. Canberra, National Health and Medical Research Council, 2013.
27.
American Diabetes Association: Nutrition recommendations and interventions for diabetes: a position statement of the American diabetes association. Diabetes Care 2008;31(suppl 1):S61-S78.
28.
Amirabdollahian F, Ash R: An estimate of phytate intake and molar ratio of phytate to zinc in the diet of the people in the United Kingdom. Public Health Nutr 2010;13:1380-1388.
29.
International Zinc Nutrition Consultative Group: Assessing Population Zinc Status with Serum Zinc Concentration. IZiNCG Technical Brief, 2007.
30.
Parnell W, Scragg R, Wilson N, Schaaf D, Fitzgerald E: NZ Food, NZ Children: Key Results of the 2002 National Children's Nutrition Survey. Wellington, Ministry of Health, 2003.
31.
Yen T, McQuilty R, Stewart P, Coakley J: Proceedings of the 10th Asian Pacific congress of clinical biochemistry in conjunction with the Australasian association of clinical biochemists' 42nd annual scientific conference. P88 Revised reference intervals for paediatric copper, zinc and selenium using ICP-MS in NSW. Clin Biochem Rev 2004;25(suppl):S18-S128.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.